Safety of Foam Sclerotherapy (UIP2013-16)

This course will discuss the safety of foam sclerotherapy and pathophysiology of nerurosensory symptoms following foam sclerotherapy. The learner will assess pre-treatment, manufactured vs. "homemade" foams, maneuvers, foam migration following injection, as well as detection of DVT and syringes and needles used for foam sclerotherapy.

This course includes:

Chair: Nick Morrison, MD, FACS, FACPh, RPhS
Discussant: Philip Coleridge–Smith, MD, FRCS
Pathophysiology of Neurosensory Symptoms Following Foam Sclerotherapy
Jean–Luc Gillet, MD
Small Volume Injection to Reduce Foam Migration
Takashi Yamaki, MD
Is Pre-Treatment for Foam Sclerotherapy Warranted?
Alessandro Frullini, MD
What is the Evidence that Total Foam Volume is Related to Safety?
Stephen Guggenbichler, MD
Is There a Difference in the Safety Profile of Manufactured Foam vs. “Homemade” Foam?
Katy Darvall, MD
Does the Type of Syringe and Needle Used for Foam Sclerotherapy Alter Safety Aspects?
Attilio Cavezzi, MD
What is the Efficacy of Maneuvers Intended to Restrict Foam Migration from the Injection Site?
Douglas Hill, MD, FACPh, FCFP
Is Pre-Treatment Testing for Right–to–Left Shunt Warranted?
Pauline Raymond–Martimbeau, MD, FACPh
All Speakers


Steps to Successfully Complete This Activity

To participate in this educational activity please follow the steps listed below.

If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.

  1. To begin the activity click the START COURSE button.
  2. Progress through course content by using the NEXT button.
  3. Complete all required items in the course.
  4. Participants must score 80% or greater on the Post-Test to advance and receive credit. They are given three attempts to meet this threshold.
  5. Track your progress using the Course Progress menu.
  6. On the final page of the activity a link will be provided to download your certificate.

Target Audience

The content of this activity is designed to meet the needs of the following target audience:  phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.

Learning Objectives

As a result of this activity, the participant should be able to:

  1. Identify methods to limit risk of adverse events with foam sclerotherapy.
  2. Explain relevant studies supporting safety measures with foam sclerotherapy.
Course summary
Course opens: 
Course expires: 
Attilio Cavezzi, MDSpeakerNonen/a
Philip Coleridge-Smith, MD, FRCSSpeakerNonen/a
Katy Darvall, MDSpeakerNonen/a
Heather Durband, BSStaffNonen/a
Alessandro Frullini, MDSpeakerGloriamed Italy; Baldacci lab; TechlamedConsultant
Antonio Gasparis, MDScientific Committee/PlannerCovidien; Cook; Vascular Insights; GoreConsultant/Speaker
Jean–Luc Gillet, MDSpeakerNonen/a
Jean-Jérôme Guex, MD, FACPhScientific Committee/PlannerServier International; Thuasne; Vascular InsightsSpeaker/Consultant; Scientific Committee Member
Stephen Guggenbichler, MDSpeakerNonen/a
Douglas Hill, MD, FACPh, FCFPSpeakerSigmacon MedicalSpeaker/Trainer
Margaret Mann, MDContent ReviewerGalderma - DysportGrant/Research Support
Mark Meissner, MDScientific Committee/PlannerNonen/a
David J. Mond, MDContent ReviewerNonen/a
Nick Morrison, MD, FACS, FACPh, RPhSScientific Committee/Planner/SpeakerMedi; Merz; BTG; VenXSpeaker; Consultant; Principal Investigator; Scientific Advisory Board
Pauline Raymond–Martimbeau, MD, FACPhSpeakerNonen/a
Melvin Rosenblatt, MD, FACPhScientific Committee/PlannerNonen/a
Cynthia Shortell, MDContent ReviewerNonen/a
Thomas Wakefield, MDScientific Committee/PlannerNonen/a
Robert Worthington-Kirsch, MD,  FSIR, FCIRSE, FASA, RVT, RPVIContent ReviewerNonen/a
Takashi Yamaki, MDSpeakerNonen/a
Steven Zimmet, MD, RVT, FACPhScientific Committee/PlannerMerz AestheticsSpeaker



The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Discussion of Off-Label Use

Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.

Reproduction Prohibited

Reproduction of this material is not permitted without written permission from the copyright owner.

Review & Recertification

This course was reviewed and recertified for AMA PRA Category 1 CreditTM in March 2015 and March 2017.


Please login or register to take this course.